David Halter

Title: **Innovative Contributions of David Halter in Medical Research**

Introduction

David Halter, an accomplished inventor based in Eindhoven, Netherlands, has made significant advancements in the field of medical research. With three patents to his name, his work is characterized by innovative methods and apparatus that contribute to the assessment of therapy suitability for cancer patients.

Latest Patents

Halter's latest patents focus on two critical areas within cancer research. The first patent, titled "Stratification of patients for assessing the suitability of a therapy," introduces a method for evaluating the suitability of therapy for patients suffering from estrogen receptor (ER) and/or progesterone receptor (PR) positive and HER2 negative cancers. This method employs a Proximity Ligation Assay to determine the activation status of an ER and/or PR signaling pathway through the detection of specific proteins involved in transcription factor complexes.

The second patent, "Apparatus for determining cellular composition information in one or more tissue samples," relates to an innovative apparatus designed for analyzing microscopic images of tissue samples. This invention provides a comprehensive approach to discern cellular composition based on both non-specific and specific staining techniques, yielding valuable insights on cell density and composition within tissue samples.

Career Highlights

Throughout his career, Halter has had the opportunity to work with renowned companies such as Koninklijke Philips Corporation N.V. and Koninklijke Philips N.V., where he has honed his expertise in medical technology and research. His work in these organizations has significantly impacted the fields of diagnostics and therapeutic applications.

Collaborations

David Halter has collaborated with several notable professionals in his field, including Reinhold Wimberger-Friedl and Anja Van De Stolpe. These collaborations have fostered innovative research and development in the medical landscape, pushing the boundaries of existing technologies for patient care.

Conclusion

David Halter stands out as a pivotal figure in medical research, dedicated to enhancing patient outcomes through his innovative inventions. His contributions, as evidenced by his latest patents and collaborative efforts, demonstrate a commitment to advancing therapy assessment methodologies and cellular analysis, making a lasting impact in the healthcare industry.